优势价格
快速发货
品质保证
技术支持
400-920-2911 sales@csnpharm.cn
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| CSN22353 | AZ3451 | 2100284-59-9 | AZ3451 is a protease-activated receptor-2 (PAR2) antagonist. |
| CSN22493 | Pumaprazole | 158364-59-1 | Pumaprazole is a reversible proton pump antagonist. |
| CSN22357 | Beperidium iodide | 86434-57-3 | Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93. |
| CSN22336 | ACP-105 | 899821-23-9 | ACP-105 is a potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen testosterone. |
| CSN22337 | Adavivint | 1467093-03-3 | Adavivint is a potent and selective inhibitor of canonical Wnt signaling, with an EC50 of 19.5 nM via a high-throughput TCF/LEF-reporter assay in SW480 colon cancer cells. |
| CSN22483 | Fezagepras sodium | 1254472-97-3 | PBI-4050 acts as an agonist for GPR40 and as an antagonist or inverse agonist for GPR84. |
| CSN22471 | Nedocromil sodium | 69049-74-7 | Nedocromil Sodium is a potent TNF-α inhibitor with an IC50 value of 1.67 μM for Blood eosinophils. |
| CSN22442 | KRN2 | 248260-75-5 | KRN2 is a selective inhibitor of nuclear factor of activated T cells (NFAT5), with an IC50 of 0.1 μM. |
| CSN22508 | SM 16 | 614749-78-9 | SM 16 is an an ATP-competitive ALK5/ALK4 inhibitor with IC50 value between 160 and 620 nM for inhibition of TGF-β1-induced Smad2/3 phosphorylation in cell study. |
| CSN22157 | Mapracorat | 887375-26-0 | Mapracorat is a novel selective glucocorticoid receptor agonist with IC 50 of 0.2 nM. |
| CSN21433 | Methyl-3β-hydroxycholenate | 20231-57-6 | L 601920-0 is a ROR gamma modulator extracted from patent US20110263046 A1, in figure 2. |
| CSN22454 | Lymecycline | 992-21-2 | Lymecycline is a tetracycline derivative, with broad-spectrum antibacterial activity and also has anti-inflammatory property. |
| CSN22143 | ERB-196 | 550997-55-2 | ERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist. |
| CSN22119 | AZD7624 | 1095004-78-6 | AZD7624 is an inhaled p38 inhibitor, with potent anti-inflammatory activity. |
| CSN22191 | MK-0429 | 227963-15-7 | MK-0429 is a potent integrin antagonist with IC50s of 12.2 nM (α5β1 integrin) and 2.8 nM (αvβ3 integrin), respectively. |
| CSN22182 | PF-4878691 | 532959-63-0 | PF-4878691 is a potent and selective Toll-like receptor 7 (TLR7) agonist. |
| CSN22183 | DW-1350 | 491577-61-8 | DW-1350 is a LTB4 receptor antagonist. |
| CSN22201 | CI-1044 | 197894-84-1 | CI-1044 is an orally active PDE4 inhibitor with IC50s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5, PDE4B2, PDE4C2 and PDE4D3, respectively. |
| CSN22186 | GW 766994 | 408303-43-5 | GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist, which has entered clinical trial for asthma and eosinophilic bronchitis. |
| CSN22167 | BMY-25271 | 78441-82-4 | BMY-25271 is a histamine H2 receptor antagonist. |
| CSN22204 | Bimosiamose | 187269-40-5 | Bimosiamose is a pan-selectin antagonist, inhibits E-, P-, and L-selectin with IC50s of 88 μM, 20 μM, and 86 μM, respectively, and can be used in the research of inflammatory disease. |
| CSN22225 | NecroX-5 | 1383718-29-3 | NecroX-5 is a derivative of the NecroX, reduces intracellular calcium concentration, and possesses anti-inflammatory and anti-cancer activity. |
| CSN22206 | Parimifasor | 1796641-10-5 | Parimifasor is an immunomodulator, with anti-inflammatory activity. |
| CSN22249 | Taprenepag isopropyl | 1005549-94-9 | Taprenepag isopropyl is a highly selective EP2 receptor agonist. |
| CSN22338 | AE-3763 | 291778-77-3 | AE-3763 is a peptide-based human neutrophil elastase inhibitor with an IC50 of 29 nM. |
| CSN22386 | Dihydromunduletone | 674786-20-0 | Dihydromunduletone is a selective adhesion G protein–coupled receptor antagonist (aGPR) with an IC50 of ~21 μM. |
| CSN22375 | Cl-amidine | 913723-61-2 | Cl-amidine is a peptidylarginine deminase (PAD) inhibitor, with an IC50 5.9±0.3 μM for PAD4. |
| CSN22388 | E-6123 | 131614-02-3 | E-6123 is a platelet-activating factor (PAF) receptor antagonist. |
| CSN22390 | E6130 | 1427058-33-0 | E6130 is an orally available and highly selective CX3CR1 modulator, that may be effective for treatment of inflammatory bowel disease. |
| CSN22333 | A-69412 | 123606-23-5 | A-69412 is a reversible, specific inhibitor of the hydrophilic 5-lipoxygenase (5-LO). |
| CSN22367 | CDK8-IN-3 | 1884500-15-5 | CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7. |
| CSN22434 | JAK-IN-5 | 2096999-92-5 | JAK inhibitor 1 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283. |
| CSN22347 | AN-3485 | 1213827-99-6 | AN-3485 is a benzoxaborole analog, Toll-Like Receptor(TLR) inhibitor with IC50 values ranging from 18 to 580 nM. |
| CSN22435 | JAK-IN-1 | 1334673-53-8 | JAK-IN-1 is a JAK1/2/3 inhibitor with IC50s of 0.26, 0.8 and 3.2 nM, respectively. JAK-IN-1 shows improved selectivity for JAK3 over JAK1. |
| CSN22372 | Olacaftor | 1897384-89-2 | CFTR corrector is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408. |
| CSN22418 | GNE-0946 | 1677667-24-1 | GNE-0946 is a potent and selective RORγ( RORc) agonist with an EC50 value of 4 nM for HEK-293 cell. |
| CSN22433 | Iralukast | 151581-24-7 | Iralukast is a cysteinyl-leukotriene antagonist (CysLT) with a pKi of 7.8 for CysLT1. |
| CSN22383 | Dagrocorat | 1044535-52-5 | Dagrocorat is a novel and dissociated Glucocorticoid Receptor Agonist. |
| CSN22419 | GNE-4997 | 1705602-02-3 | GNE-4997 is a potent and selective ITK/TSK inhibitor. |
| CSN22420 | GNE-6468 | 1677668-27-7 | GNE-6468 is a potent and selective RORγ(RORc) agonists with an EC50 value of 13 nM for HEK-293 cell. |
| CSN22521 | TNF-α-IN-1 | 444287-49-4 | TNF-α-IN-1 is a TNF-α inhibitor extracted from patent US20030096841A1, compound example I-7. |
| CSN22409 | Gefapixant | 1015787-98-0 | Gefapixant is an orally active P2X3 receptor (P2X3R) antagonist with IC50s of ~30 nM versus recombinant hP2X3 homotrimers and 100-250 nM at hP2X2/3 heterotrimeric receptors. |
| CSN22498 | ROCK2-IN-2 | 1995065-79-6 | ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC50 of <1 μM. |
| CSN22421 | GPR84 antagonist 8 | 1445846-30-9 | GPR84 antagonist 8 is a selective GPR84 antagonist. |
| CSN22523 | Trehalose 6-behenate | 66755-19-9 | Trehalose 6-behenate is a Th1/Th17 skewing vaccine adjuvant. |
| CSN22422 | GSK 4027 | 2079896-25-4 | GSK 4027 is a chemical probe for the PCAF/GCN5 bromodomain with an pIC50 of 7.4±0.11 for PCAF in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. |
| CSN22535 | YM-264 | 131888-54-5 | YM-264 is a selective, potent and orally active platelet-activating factor (PAF) antagonist with a pKi value of 8.85 for rabbit platelet membranes. |
| CSN22482 | PAT-505 | 1782070-22-7 | PAT-505 is a potent, selective, noncompetitive and orally available autotaxin inhibitor, with an IC50 of 2 nM in Hep3B cells, 9.7 nM in human blood and 62 nM in mouse plasma. |
| CSN22495 | RGX-104 hydrochloride | 610318-03-1 | RGX-104 is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene. |
| CSN24268 | Mitoquinone mesylate | 845959-50-4 | Mitoquinone Mesylate is a ubiquinone derivative, TPP-based and mitochondrially targeted antioxidant, preventing lipid peroxidation-induced apoptosis and protecting mitochondria from oxidative damage. |
